Neurotrophin 3 induces structural and functional modification of synapses through distinct molecular mechanisms by Je, Hyun-Soo et al.
T
H
E
J
O
U
R
N
A
L
O
F
C
E
L
L
B
I
O
L
O
G
Y
JCB: ARTICLE
The Journal of Cell Biology, Vol. 175, No. 6, December 18, 2006 1029–1042
http://www.jcb.org/cgi/doi/10.1083/jcb.200603061
JCB 1029
Introduction
Remarkably, neurons have the ability to undergo long-lasting 
changes in the strength and pattern of their synaptic connecti-
vity in response to environmental stimuli. Long-term modifi  ca-
tion of synapses is thought to mediate many aspects of brain 
functions, particularly learning and memory (Goelet et al., 
1986). In general, long-term synaptic plasticity has two distinct 
features. First, long-lasting changes in the structure of synapses 
accompany alterations in synaptic effi  cacy that include both 
the modifi  cation of existing synapses and the formation of new 
  synapses. Second, long-term synaptic plasticity requires changes 
in gene expression and new protein synthesis (Davis and Squire, 
1984; Yin and Tully, 1996). The transcription factor cAMP 
  response element (CRE)–binding protein (CREB) is thought 
to play a key role in the synthesis of new proteins required for 
long-term synaptic plasticity.
CREB, which is a member of basic leucine zipper (bZIP) 
family of dimeric transcription factors, controls the expres-
sion of many plasticity-related genes through binding to the 
CRE. Numerous studies have established that CREB plays a 
critical role in long-term synaptic plasticity and memory in a 
variety of model systems, such as fl  ies, mollusks, and rodents 
(Silva et al., 1998; Kandel, 2001; Lonze and Ginty, 2002; 
West et al., 2002; Deisseroth et al., 2003). Is CREB involved 
in both structural and functional modifi  cations of synapses? 
Inhibition of CREB activity in Aplysia blocks both long-term 
facilitation of synaptic effi  cacy and synaptic growth (Bartsch 
et al., 1995). In Drosophila melanogaster, however, CREB 
controls only functional, and not structural, synaptic plasticity 
(Davis et al., 1996). Gene knockout experiments in mice 
have yielded variable results regarding hippocampal synaptic 
  plasticity. Some investigators have reported that disruption 
of CREB function impairs some forms of long-term potentia-
tion (LTP; Bourtchuladze et al., 1994; Pittenger et al., 2002), 
whereas others fi  nd no considerable LTP defi  cits (Gass et al., 
1998; Rammes et al., 2000; Balschun et al., 2003; Ramanan 
et al., 2005). There is some evidence that CREB is also involved 
in structural changes at hippocampal synapses (Murphy and 
Segal, 1997).
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he mechanisms by which neurotrophins elicit long-
term structural and functional changes of synapses 
are not known. We report the mechanistic separa-
tion of functional and structural synaptic regulation by 
neurotrophin 3 (NT-3), using the neuromuscular synapse 
as a model. Inhibition of cAMP response element (CRE)–
binding protein (CREB)–mediated transcription blocks the 
enhancement of transmitter release elicited by NT-3, with-
out affecting the synaptic varicosity of the presynaptic 
terminals. Further analysis indicates that CREB is acti-
vated through Ca
2+/calmodulin-dependent kinase IV 
(CaMKIV) pathway, rather than the mitogen-activated 
protein kinase (MAPK) or cAMP pathway. In contrast, in-
hibition of MAPK prevents the NT-3–induced structural, 
but not functional, changes. Genetic and imaging experi-
ments indicate that the small GTPase Rap1, but not Ras, 
acts upstream of MAPK activation by NT-3. Thus, NT-3 
initiates parallel structural and functional modiﬁ  cations of 
synapses through the Rap1–MAPK and CaMKIV–CREB 
pathways, respectively. These ﬁ  ndings may have implica-
tions in the general mechanisms of long-term synaptic 
modulation by neurotrophins.
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Recently, neurotrophins have emerged as major factors 
that regulate synaptic structure and function (Poo, 2001; Lu, 
2003; Lu and Je, 2003). These factors are widely expressed in 
the brain, and can elicit both acute and long-term modifi  cations 
of synapses (Lu, 2004). In general, neurotrophins bind to their 
cognate Trk receptor tyrosine kinases and initiate their synaptic 
functions through the following three signaling pathways: 
MAPK, phosphatidylinositol 3-kinase, and PLC-γ (Kaplan and 
Miller, 2000; Huang and Reichardt, 2003). An important task is 
to determine the signaling mechanisms for specifi  c neurotroph-
ins in specifi  c aspects of synaptic modulation. Several lines of 
evidence suggest that long-term synaptic modulation by neuro-
trophins also involves synaptic growth and requires new protein 
synthesis (Lu, 2004). Long-term treatment of hippocampal 
slices with brain-derived neurotrophic factor increases the num-
ber of synapse, spine density, and synaptic proteins in rodent 
CA1 pyramidal neurons (Tartaglia et al., 2001; Tyler and Pozzo-
Miller, 2001). In cultured Xenopus laevis neuromuscular syn-
apses, long-term exposure to neurotrophin-3 (NT-3) induces a 
series of profound structural changes, specifi  cally, an increase 
in the number and size of synaptic varicosities (Wang et al., 
1995). In a recent study, we demonstrated that the long-term 
structural changes at the neuromuscular synapses induced 
by NT-3 require protein synthesis in the presynaptic neurons 
(Je et al., 2005).
Does long-term synaptic modulation by neurotrophins re-
quire the transcription factor CREB? What are the relationships 
between structural and functional changes at synapses induced 
by neurotrophins? In this study, we used the X. laevis neuro-
muscular synapses as a model system to study the signaling 
mechanisms underlying the structural and functional plasticity 
induced by NT-3. We demonstrated that although NT-3–induced 
enhancement in the effi  cacy at a single synapse requires CREB 
activation in presynaptic neurons, the long-term increase in the 
number of synaptic sites elicited by NT-3 is CREB- independent. 
Instead, the morphological changes in the presynaptic terminals 
require activation of the MAPK pathway. Thus, the structural 
and functional synaptic modifi  cations by NT-3 are mediated by 
separate mechanisms. Using various imaging tools, we have 
also identifi  ed signaling events upstream of CREB and MAPK. 
Together, these data argue that a concomitant activation of 
CaMKIV–CREB–mediated transcription and sustained Rap1–
MAPK signaling may be necessary for the long-term functional 
and structural changes necessary for neurotrophin-dependent 
synaptic modulation.
Results
Requirement of CREB activation in NT-3–
induced long-term synaptic potentiation
CREB activation is critical for several forms of sustained syn-
aptic plasticity (Kandel, 1997, 2001; Silva et al., 1998). It is un-
clear, however, whether CREB mediates the long-term synaptic 
modulation by neurotrophins. To measure CREB activation, we 
used an antibody that detects the phosphorylation at serine 133 
of CREB. X. laevis spinal neurons exhibited rapid activation of 
CREB (<30 min) after NT-3 treatment (5 ng/ml), as indicated 
by dark nuclear staining (Fig. 1 A). To better quantify CREB 
  activation, we used immunofl  uorescence, and measured the peak 
fl  uorescence intensity in the nuclear region (Fig. 1, B and C, 
and Fig. S1 A, available at http://www.jcb.org/cgi/content/full/
jcb.200603061/DC1). Compared with untreated neurons, NT-3 
treatment increased the level of fl  uorescence signals in the nucleus 
of spinal neurons by threefold (Fig. 1 C).
CREB can be phosphorylated on serine 133 by multiple 
kinases, including protein kinase A (PKA), calcium/ calmodulin-
dependent kinases (CaMKs), and MAPK. To identify the sig-
naling pathways mediating the CREB activation, we examined 
phospho-CREB (pCREB) fl  uorescence in cultured spinal neu-
rons in the presence of inhibitors specifi  c for these   pathways. 
Pretreatment of spinal neurons with the MAPK kinase (MEK) 
inhibitor PD098059 (10 μM; Alessi et al., 1995) or PKA inhib-
itor Rp-cAMP (5 μM; Matthies and Reymann, 1993) for 1 h 
could not attenuate the increase in pCREB fl  uorescence after 
NT-3 application (Fig. 1 C). In contrast, pretreatment with the 
CaM kinase inhibitor KN93 (1 μM; Corsi et al., 1998) com-
pletely prevented the increase in pCREB fl  uorescence induced 
by NT-3 (Fig. 1 C). These data suggest that CREB activation, 
at least within 1 h after NT-3 application, is mediated through 
the CaMKs.
It has been reported that in hippocampal neurons, CaM-
KIV is responsible for early activation of CREB, whereas the 
late, sustained phosphorylation of CREB depends on MAPK 
activity (Wu et al., 2001b). To examine whether CaMK or 
MAPK mediates the sustained CREB phosphorylation in devel-
oping spinal neurons, we monitored the time course of CREB 
activation in the presence or absence of specifi  c inhibitors. NT-3 
treatment signifi  cantly increased CREB phosphorylation as early 
as 30 min, and maximum activation of CREB was observed 1 h 
after NT-3 treatment (P < 0.05; Fig. 1 D). This increase was 
maintained at 93% level until 24 h after NT-3 treatment, indicat-
ing that NT-3 induced a sustained phosphorylation of CREB. 
The sustained activation of CREB was abolished by KN93, but 
not PD098059 (Fig. 1 D). Thus, in developing spinal neurons, 
NT-3–induced CREB phosphorylation is mediated by CaMKs, 
not MAPK.
NT-3 is known to induce both acute and long-term changes 
in synaptic effi  cacy at the neuromuscular synapses (Wang et al., 
1995; Liou and Fu, 1997; Liou et al., 1997; Lu and Je, 2003). To 
determine whether CREB activation is necessary for either the 
acute or the long-term effects of NT-3, we introduced dominant-
negative CREB (DnCREB) mutants into spinal neurons by em-
bryo injection. Two different DnCREB mutants were used; the 
K-CREB, a mutant that contains mutations in the DNA-binding 
domain of CREB; and the A-CREB, a mutant that contains 
  basic-to-acidic residue mutations within the CREB bZIP domain 
(Walton et al., 1992; Ahn et al., 1998). These variants of CREB 
proteins act as dominant repressors for gene transcription by 
forming an inactive dimer with endogenous CREB and block-
ing its ability to bind cAMP response element (CRE). There-
fore, expression of these DnCREB mutants cannot change the 
phosphorylation status of Ser133 in the endogenous CREB, but 
can still inhibit CREB-mediated gene transcription. The mRNAs 
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one blastomere of X. laevis embryos at the two-cell stage. 
Nerve-muscle cocultures were prepared from the injected em-
bryos after 24 h. Expression of K-CREB in spinal neurons had 
no effect on the basal synaptic transmission. The frequency of 
spontaneous synaptic currents (SSCs) recorded from K-CREB–
positive (N+) and K-CREB–negative (N−) neurons were 4.7 
± 0.5 events/min (n = 11) and 4.3 ± 0.6 events/min (n = 7), 
respectively. Moreover, identical to that observed in control 
synapses (N–), acute application of NT-3 induced an increase in 
frequency, but not amplitude, of SSCs (Fig. 2 A). Collectively, 
inhibition of CREB activation does not affect the acute modula-
tion of transmission by NT-3.
In contrast, expression of K-CREB in presynaptic neurons 
completely blocked the enhancement of synaptic effi  cacy in-
duced by long-term exposure to NT-3. In a culture treated 
with NT-3 for 48 h, the mean SSC frequency of the synapses 
made by K-CREB–expressing neurons was reduced to the level 
of NT-3–untreated neurons (Fig. 2 B). However, expression of 
K-CREB in the postsynaptic muscle cells had no effect on 
NT-3–induced long-term synaptic potentiation (Fig. 2 B), sug-
gesting that CREB activation is only required in presynaptic 
neurons. Moreover, expression of K-CREB either pre- or post-
synaptically had no effect on SSC amplitude, whether the syn-
apses were treated with NT-3 or not (Fig. S2 A, available 
at http://www.jcb.org/cgi/content/full/jcb.200603061/DC1). 
Almost identical results were obtained from synapses express-
ing A-CREB presynaptically (Fig. 2 C). In addition to potentiat-
ing spontaneous synaptic activity, long-term treatment with 
NT-3 enhances functional synaptic transmission, as refl  ected by 
an increase in the amplitude of evoked synaptic currents (ESCs), 
which are elicited by stimulating presynaptic somata of spinal 
neurons (Je et al., 2005). Expression of K-CREB in presynaptic 
spinal neurons completely blocked the increase in ESC ampli-
tude induced by NT-3 (Fig. 2 D). Collectively, these results sug-
gest that presynaptic activation of CREB is required for NT-3–
induced long-term, but not acute, synaptic transmission at the 
neuromuscular synapses.
Long-term physiological effect of NT-3 
mediated by the CaMKIV–CREB pathway
Given that CaMK signaling was required for NT-3–induced 
CREB activation (Fig. 1, C and D), we next asked whether the 
CaMK pathway also mediates the long-term effects of NT-3. 
Treatment with NT-3 for 48 h increased the frequency of SSCs 
by  2.5-fold over untreated control cells (Fig. 3 A). In contrast, 
in cultures pretreated with 1 μM KN93, NT-3 elicited no in-
crease in SSC frequency, indicating that NT-3–induced synaptic 
potentiation requires activation of the CaMK signaling  pathway. 
Inhibition of either MAPK (Je et al., 2005) or PKA (Fig. S2 D) 
did not exhibit statistically signifi  cant change in NT-3–induced 
long-term physiological effects. Therefore, these data suggest 
that the NT-3–induced long-term physiological effect is primar-
ily mediated through a CaMK-dependent mechanism.
KN93 is a general inhibitor of CaMK family members, 
which include CaMKI, CaMKII, and CaMKIV, but CaMKI 
and CaMKII are enriched in neuronal processes and synapses, 
Figure 1.  NT-3 activates CREB via CaMKs. 
X. laevis nerve-muscle cultures were treated with 
or without inhibitors for 1 h, followed by appli-
cation of NT-3. The cultures were ﬁ  xed 30 min 
later and processed for immunocytochemistry 
using anti-pCREB antibody. (A) pCREB staining 
images of cultures treated with or without 
5 ng/ml NT-3. The yellow arrow indicates 
dark nuclear staining by pCREB. N, neuron; 
M, muscle cell. Bar, 20 μm. (B) Fluorescence 
intensity proﬁ  les of pCREB staining in the cell 
body of spinal neurons. Higher magniﬁ  cation 
of neuronal cell body is shown in the top right 
corner. The intensity of pCREB ﬂ  uorescence 
was monitored along the axis drawn on the 
cell body of spinal neurons. Bar, 10 μm. n = 8 
for untreated neurons; n = 10 for NT-3–treated 
neurons. (C) Quantiﬁ  cation of peak intensity of 
pCREB ﬂ  uorescence under various conditions. 
The number associated with each column rep-
resents the number of cells analyzed. *, signi-
ﬁ   cantly higher than the respective NT-3(–) 
group, by ANOVA, followed by post hoc tests; 
P < 0.01. (D) Time course of CREB activation 
upon NT-3 treatment with or without 10 μM 
MAPK inhibitor (PD098059) or 1 μM CaMK 
inhibitor (KN93). The peak intensities of pCREB 
ﬂ  uorescence at various time points were moni-
tored after NT-3 treatment. Data are presented 
as the mean ± the SEM.JCB • VOLUME 175 • NUMBER 6 • 2006  1032
whereas CaMKIV is relatively enriched in the nucleus (Deisseroth 
et al., 1998; Finkbeiner et al., 1997; Picciotto et al., 1995). The 
nuclear localization of CaMKIV suggests its ability to link 
  extracellular signals to CREB activation in the nucleus. There-
fore, we tested whether CaMKIV mediates both CREB activa-
tion and the long-term synaptic effects elicited by NT-3 by using 
Dn-CaMKIV. This mutant of CaMKIV bears a T196A muta-
tion, which disrupts CaMKIV from binding to CaMKIV kinases 
(Tokumitsu et al., 1994). Expression of the Dn-CaMKIV mutant 
was refl  ected by GFP fl  uorescence in cultured spinal neurons 
(Fig. 3 B). NT-3 treatment for 30 min caused an approximately 
fourfold increase in pCREB immunoreactivity in control spinal 
neurons, but not in neurons expressing Dn-CaMKIV (Fig. 3 C). 
These fi  ndings are consistent with a recent study showing that 
expression of Dn-CaMKIV could attenuate CREB activation 
and CREB-mediated transcription in hippocampal neurons 
(Kang et al., 2001).
Cells expressing the Dn-CaMKIV mutant did not display 
any defect in growth or morphology (unpublished data). To de-
termine whether CaMKIV activation is required for long-term 
effects of NT-3 on synaptic transmission, we measured SSC 
  frequency in spinal neurons expressing Dn-CaMKIV mutant. 
  Expression of Dn-CaMKIV in spinal neurons completely blocked 
the enhancement of synaptic effi  cacy induced by long-term 
  exposure to NT-3 (Fig. 3, D and E). In cultures treated with 
NT-3 for 48 h, the frequency of SSCs in the synapses made by 
Dn-CaMKIV–expressing neurons was signifi  cantly lower than 
that in synapses made by nonexpressing control neurons in the 
same dishes (Fig. 3 D). Dn-CaMKIV had no effect on SSC 
amplitude, suggesting a pure presynaptic effect (Fig. S2 B). 
  Expression of Dn-CaMKIV in presynaptic neurons also   completely 
prevented the potentiating effect of NT-3 on ESC amplitude 
(Fig. 3 E). Inhibition of CaMKII with a specifi  c peptide inhibi-
tor blocked the acute potentiation of synaptic transmission by 
NT-3 (He et al., 2000). In neurons expressing the Dn-CaMKIV, 
however, acute application of NT-3 could still elicit a marked 
increase in SSC frequency (Fig. S3, available at http://www.jcb.
org/cgi/content/full/jcb.200603061/DC1). Thus, the acute ef-
fect of NT-3 on synaptic transmission is mediated by CaMKII, 
whereas the long-term effect is mediated by CaMKIV. These 
results suggest that the long-term effect of NT-3 on synaptic 
transmission is mediated by the CaMKIV–CREB pathway.
NT-3–induced translocation of GFP-CaM 
into nucleus
CaMKIV activation requires the translocation of Ca
2+-calmodulin 
(CaM) into the nucleus, and such nuclear translocation of CaM 
appears to be important for the activation of CaMKIV–CREB 
pathway (Deisseroth et al., 1998). To test whether NT-3 is capable 
of inducing nuclear localization of CaM, we expressed GFP-
CaM fusion protein in spinal neurons (Li et al., 1999).  Expression 
of GFP-CaM did not affect the normal growth or morphology of 
Figure 2.  Presynaptic expression of DnCREB 
prevents the long-term effect of NT-3 on syn-
aptic transmission. In this and all other ﬁ  gures, 
presynaptic expression of a speciﬁ  c gene was 
achieved by embryo mRNA injection. The 
acute effect of NT-3 was studied by directly 
applying 25 ng/ml NT-3 to 1-d-old cultures, 
and the long-term effect of NT-3 was studied 
by treating cultures with 5 ng/ml NT-3 for 48 h. 
The frequency of SSCs was used to   monitor 
changes in synaptic efﬁ  cacy.  (A)  Inhibition 
of CREB activation did not prevent acute 
  potentiation of synaptic transmission by NT-3. 
(top) A sample recording showing that acute 
application of NT-3 still elicits a rapid increase 
in the frequency of SSCs recorded from a 
synapse in which K-CREB is expressed presyn-
aptically (N+). (bottom) Summary of effect of 
acute application of NT-3 on control synapses 
(N–) without K-CREB, and synapses with pre-
synaptic (N+) expression of K-CREB. Each 
data point represents normalized SSCs fre-
quency (averaged from 10 min of recording) 
from a single synapse before and after NT-3 
application. (B and D) Presynaptic, but not 
postsynaptic, expression of K-CREB prevents 
NT-3–induced long-term synaptic potentia-
tion on SSC frequency (B) and ESC amplitude 
(D). M+, K-CREB expressed postsynaptically. 
(C) Presynaptic expression (N+) of A-CREB 
prevents NT-3–induced long-term synaptic 
  potentiation. The number associated with each 
column represents the number of cells analyzed. 
Data are presented as the mean ± the SEM.MECHANISMS FOR STRUCTURAL AND FUNCTIONAL PLASTICITY • JE ET AL. 1033
neurons (Fig. 4 A, left). Western blot showed the expression of 
GFP-CaM in X. laevis neural tubes 2 d after embryonic DNA 
injection. In embryos injected with GFP-CaM cDNA, a promi-
nent band of 47 kD was detected using an anticalmodulin 
 antibody. This band was also stained positively with antibody 
against GFP, confi  rming the expression of GFP-CaM fusion 
protein (Fig. 4 A, right).
We next studied the NT-3–induced movement of GFP-CaM 
in spinal neurons. GFP-CaM fl  uorescence was monitored in 
the nucleus and axonal periphery of neurons. Before application 
of NT-3, culture medium was replaced with Ringer’s solution 
for 2 h to reduce the background CaM movement caused by 
unspecifi  ed factors accumulated in the medium. Fluorescence 
intensity changes of selected areas in the nucleus and axons 
of a neuron (indicated by dotted lines in Fig. 4 B, top) upon 
NT-3 application were monitored by using time-lapse micros-
copy. Application of NT-3 evoked a rise in the fl  uorescence in 
the nucleus, paralleling a decrease in the fl  uorescence inten-
sity in the axons (Fig. 4 B, top). The increase in nuclear CaM 
fl  uorescence was relatively fast; within 20 min, the nuclear 
fl  uorescence reached a plateau (Fig. 4 B, bottom left). In all 
experiments, the total averaged cellular fl  uorescence (corrected 
for photobleaching effects) remained unchanged, indicating 
that observed fl  uorescence intensity changes are caused by 
Figure 3.  NT-3–induced CREB activation and long-term 
physiological change are mediated by CaMKIV. (A) Inhibition 
of CaMKs prevents NT-3–induced long-term synaptic 
  potentiation. Cultures were treated with or without 1 μM 
KN93, which is a speciﬁ  c inhibitor for CaMKs. (B and C) 
Expression of Dn-CaMKIV abolishes CREB activation in-
duced by NT-3. (B) Bright-ﬁ  eld (top left), pCREB (top right, 
red), Dn-CaMKIV (bottom left, green), and merged ﬂ  uores-
cence images (bottom right) of three spinal neurons, two of 
which express Dn-CaMKIV, as indicated by coexpression 
of GFP. After application of NT-3, the Dn-CaMKIV–  negative 
neuron exhibit marked CREB phosphorylation (red). 
In contrast, the Dn-CaMKIV–expressing neuron (green) 
shows no CREB phosphorylation. Note that the neuron in 
the middle expresses a lower level of Dn-CaMKIV and shows 
a reduced CREB phosphorylation. Bar, 10 μm. White 
dashed lines indicate the outline of neuronal cell bodies. 
(C) Quantitative analysis of pCREB levels in Dn-CaMK (+) 
and (–) neurons before and after NT-3 application. (D and E) 
Inhibition of NT-3–induced long-term synaptic potentiation 
by presynaptic expression of Dn-CaMKIV. Dn-CaMKIV 
was expressed in spinal neurons. SSC frequency and ESC 
amplitude were measured in synapses treated with or with-
out NT-3 for 2 d. (D) Effects on SSC frequency. (E) Effects 
on ESC amplitude. The number associated with each 
  column represents the number of cells analyzed. Data are 
presented as the mean ± the SEM.JCB • VOLUME 175 • NUMBER 6 • 2006  1034
redistribution of GFP-CaM. Application of NT-3 for 30 min 
increased the intensity of nuclear fl  uorescence by 29%, but 
decreased that of the axonal fl  uorescence by 35%. These results 
indicate that application of NT-3 evoked active translocation of 
CaM from nonnuclear regions into nuclear region in neurons.
Long-term morphological effects of NT-3 
mediated by MAPK pathway
In addition to physiological changes, long-term treatment with 
NT-3 induces the morphological development of presynaptic 
terminals (Liou and Fu, 1997; Wang et al., 1995). Using FM dye 
to label endocytosed synaptic vesicles, our previous study 
showed that chronic, but not acute, treatment with NT-3 pro-
motes the formation of “synaptic varicosities,” which are en-
largements along the axons that refl  ect clusters of synaptic 
vesicles and other presynaptic elements (Je et al., 2005). There 
are two potential problems associated with this approach. First, 
FM dye also labels postsynaptic membrane structures and 
organelles. To avoid this problem, we visualized the synaptic 
varicosity by expressing a fusion protein in which GFP is fused 
with the C terminus of synaptophysin (SYP-GFP), a major inte-
gral membrane protein of synaptic vesicles (Alsina et al., 2001; 
Ruthazer et al., 2006). SYP-GFP was coinjected with rhodamine-
dextran in X. laevis embryos so that we could simultaneously 
label axonal morphology and synaptic varicosity (Fig. 5, A–C). 
Furthermore, to ensure that SYP-GFP labels functional synaptic 
vesicles, neurons transiently transfected with SYP-GFP were 
loaded with FM 4–64 dye. We found that that SYP-GFP fl  uores-
cence overlapped completely with FM dye–labeled structures at 
the presynaptic terminals (Fig. 6). The second problem is that 
labeling presynaptic vesicles alone may not faithfully reveal 
specifi  c changes in the presynaptic terminals at the synapses. 
Therefore, we labeled postsynaptic acetylcholine receptors 
(AChRs) with a low concentration of Cy5-labeled α-bungarotoxin 
(Fig. 5 D, Cy5-α-BTX). The “synaptic site” was revealed by the 
juxtaposition of presynaptic SYP-GFP (green) and postsynaptic 
AChR (Fig. 5, E and F, red).
Using the double-labeling technique, we showed that 
chronic treatment (48 h) of NT-3 signifi  cantly increased the num-
ber of synaptic sites (Fig. 7 A). To test the role of CREB in NT-3–
induced long-term morphological changes, we inhibited CREB 
activation by expressing K-CREB in spinal neurons and quanti-
fi  ed the changes in synaptic sites. Treatment with NT-3 induced a 
twofold increase in the number of synaptic sites per myocyte. 
Surprisingly, although expression of K-CREB blocked the 
physiological changes of synapses triggered by NT-3, expres-
sion of K-CREB in spinal neurons could not inhibit a NT-3–
 induced increase in synaptic sites (Fig. 7 B). These results suggest 
that CREB activation is only required for functional, but not 
structural, changes of synapses induced by NT-3. Furthermore, 
these results raise the possibility of parallel signaling pathways 
mediating NT-3–induced functional and morphological changes.
Figure 4.  NT-3 induces the translocation of CaM into the nucleus 
of spinal neurons. (A) Expression of the GFP-CaM fusion gene in 
X. laevis spinal neurons. Hoffman and ﬂ  uorescent images (left and 
middle) show a spinal neuron expressing GFP-CaM. Bars (A and B), 
20 μm. (right) Western blots showing the expression of the GFP-
CaM in 1-d-old neural tubes injected with or without (Control) 
CaM mRNA. (B) Redistribution of CaM in spinal neurons induced 
by NT-3. (top) Color-coded images of a CaM-GFP–expressing spinal 
neuron before and after NT-3 application. Two ROIs for monitor-
ing ﬂ  uorescence changes (free-hand ROI traces over nucleus and 
axon) are shown. At the peak of the response (30 min after NT-3 
application), the nuclear area is bright red, indicating a substan-
tial accumulation of GFP-CaM in the region. (bottom) Application 
of NT-3 evoked a slow, but sustained, increase (from 10 min after 
NT-3 application) in the ﬂ  uorescence signal from the nucleus 
  region (blue trace), accompanied by a corresponding decrease 
in the ﬂ  uorescence intensity from the axonal area (pink trace). 
Averaged ﬂ  orescence signals at 30 min are shown on the right. 
The number associated with each column represents the number of 
cells analyzed. Data are presented as the mean ± the SEM. MECHANISMS FOR STRUCTURAL AND FUNCTIONAL PLASTICITY • JE ET AL. 1035
What are the signaling pathways that mediate the increase 
in the number of synaptic sites induced by long-term exposure 
to NT-3? NT-3 is known to activate MAPK in X. laevis spinal 
neurons (Yang et al., 2001). Given that neurotrophins have been 
shown to promote neurite outgrowth via MAPK pathway in cor-
tical neurons and PC12 cells (Markus et al., 2002), we sought to 
test whether MAPK activation is required for NT-3–induced in-
crease in synaptic varicosity. Treatment with the MEK inhibitor 
U0126, which is known to block NT-3–induced MAPK activa-
tion (Yang et al., 2001), completely blocked changes in synaptic 
sites elicited by NT-3 (Fig. 7 C). However, neither the PKA in-
hibitor Rp-cAMP nor the CaMK inhibitor KN93 could block 
the NT-3 effect (Fig. 7 C). These results, together with the fi  nd-
ing that MAPK is not involved in the long-term changes in syn-
aptic effi   cacy induced by NT-3 (Je et al., 2005), reveal a 
complementary role of MAPK and CREB; MAPK mediates the 
morphological, whereas CREB mediates physiological, changes 
induced by NT-3.
Requirement of Rap1, but not Ras, 
for long-term morphological effects of NT-3
If CaMKIV is the upstream activator for CREB that mediates 
the functional changes of synapses upon NT-3 treatment, what 
is the upstream activator for MAPK that mediates the struc-
tural change of synapse induced by NT-3? In PC12 cells, Ras 
and Rap1, two related small GTP-binding proteins of the Ras 
subfamily, have been shown to mediate transient and sustained 
activation of MAPK, respectively (York et al., 1998). To moni-
tor the kinetics of Ras and Rap1 activation by NT-3 in living 
spinal neuron, we used fl  uorescent resonance energy transfer 
(FRET) techniques using Raichu-Ras and -Rap1 constructs 
(Mochizuki et al., 2001). Raichu-Ras contains a pair of mutant 
fl  uorescence proteins (YFP and CFP) in its C terminus. Thus, 
activation of Ras caused by intramolecular binding of the Ras 
domain to the RafRBD domain brings CFP close to YFP, lead-
ing to FRET from CFP to YFP (Fig. 8 A). Raichu-Rap1 works 
very similarly, except Ras is replaced with Rap1. We found that 
Figure 5.  Synaptic sites are revealed by 
double labeling with SYP-GFP and Cy5-𝗂-BTX. 
(A) Phase-contrast image of nerve-muscle 
coculture. M, myocytes. (B) Labeling of axons 
of a spinal neuron by rhodamine dextran. 
(C) Labeling of synaptic varicosities by SYP-
GFP. Note the discrete SYP puncta located in 
presynaptic terminals innervating the myocytes. 
(D) Labeling of postsynaptic AChRs with 
Cy5-α-BTX. (E) Merge of images in C and D. 
(F) Enlargement of the areas boxed in E. Note 
that SYP-GFP (green) and Cy5-α-BTX (red) 
puncta are juxtaposed against each other at 
the synapses. Bar, 10 μm.
Figure 6.  SYP-GFP–labeled synaptic varicosities are 
colocalized with FM dye–labeled puncta. Neurons transiently 
transfected with SYP-GFP were loaded with FM 4–64 dye 
by rapid depolarization (2 min) with high K
+ and neu-
rons, followed by extensive washing.(A) Phase-contrast 
images of nerve-muscle coculture. (B) Labeling of synaptic 
varicosities by SYP-GFP. (C) Labeling of synaptic varicosities 
by FM 4–64. Yellow arrows indicate synaptic varicosities 
in which SYP-GFP and FM dye are colocalized. (D) Merge 
of images in B and C. More than 20 neurons were exam-
ined, and consistent colocalization of SYP-GFP and FM 
dye were observed in puncta located in the synaptic 
regions. Bar, 10 μm.JCB • VOLUME 175 • NUMBER 6 • 2006  1036
the activation of Ras differed from that of Rap1 in two ways. 
First, Ras activation, as refl  ected by the color change, was faster 
and more transient than Rap1 activation (Fig. 8, A [top] and B). 
Ras activation reached its maximum in <10 min and was di-
minished in 90 min (Fig. 8 B). This may refl  ect the localization 
of Ras at the plasma membrane, where NT-3/TrkC signals were 
rapidly transduced (Fig. 8 B). In contrast, Rap1 activation was 
much slower and more sustained. Second, Ras activation was 
observed not only in the cell body, but also in the axonal pro-
cesses. In contrast, Rap1 activation was concentrated primarily 
at the neuronal cell body and never extended to the axons 
(Fig. 8, A [bottom] and B). Thus, although Ras and Rap1 could 
both be activated by NT-3, they showed different spatial and 
temporal activation patterns.
Next, we asked whether the inhibition of Ras or Rap1 
could block the long-term structural and functional change in-
duced by NT-3. To test this, we expressed Dn-Ras or -Rap1 in 
X. laevis spinal neurons by embryo injection, and the nerve-
muscle cocultures were treated with NT-3 for 2 d. Expression of 
Dn-Ras and -Rap1 did not affect basal synaptic transmission 
(compare the white bars in Fig. 8 C). Moreover, long-term treat-
ment with NT-3 induced a similar increase in SSC frequency in 
control neurons and neurons expressing either Dn-Ras or -Rap1 
(Fig. 8 C and Fig. S2 C). However, expression of Dn-Rap1, but 
not Dn-Ras, completely blocked the long-term effect of NT-3 
on synaptic sites (Fig. 8 D). These data, together with the spatio-
temporal pattern of Rap1 activation induced by NT-3, suggested 
that the Rap1–MAPK pathway was responsible for NT-3–
  induced long-term structural, but not functional, changes at the 
neuromuscular synapses.
Discussion
It is well known that neuronal activity elicits long-term changes 
in the structure and function of synapses. Neurotrophins have 
recently emerged as a class of important regulators for synapse 
development and function. Neurotrophin-induced long-term 
synaptic changes resemble activity-dependent long-term syn-
aptic plasticity in two fundamental ways: synaptic growth and 
dependence on protein synthesis (Lu, 2004). A question of general 
interests is whether neuronal activity and neurotrophins use the 
same or different molecular mechanisms to modulate synapses. 
In this study, we show that NT-3 induced two parallel molecular 
pathways. One involves the CaMKIV–CREB pathway, which is 
responsible for enhancement of synaptic effi  cacy, but not syn-
aptic growth. The other involves Rap1–MAPK, which leads to 
increase in the number of synaptic sites, but not in synaptic 
transmission. To our knowledge, no study so far has demon-
strated that neuronal activity triggers two parallel, but distinct, 
signaling pathways for structural and functional plasticity in 
vertebrate synapses. Thus, although similar molecules are used 
to mediate synaptic modulation induced by either neuronal ac-
tivity or neurotrophins, the specifi  c mechanisms underlying the 
two types of synaptic modulation are not the same.
The results obtained from this study, together with our 
previous fi  ndings and those of other laboratories, support a 
model in which neurotrophins, through activation of Trk recep-
tor tyrosine kinases, induce long-term structural and functional 
changes at synapses through two parallel signaling pathways 
(Fig. 9). The Ca
2+–CaMKIV–CREB pathway ensures matura-
tion of transmitter-release machinery for effi  cient functional 
transmission. The endocytosed Trk receptors and activation 
of Rap1–MAPK pathway promotes synaptic growth, leading 
Figure 7.  Long-term NT-3 treatment increases the number of synaptic 
sites via MAPK, but not CREB. (A) Effect of NT-3 on the number of synaptic 
sites. Synaptic sites (yellow spots, indicated by yellow arrows) are re-
vealed by synaptic boutons (labeled by SYP-GFP, green) directly juxta-
posed to postsynaptic AChR (labeled by Cy5-α-BTX; red). (B) Failure of 
K-CREB to block a NT-3–induced increase on synaptic sites. (C) Selective 
blockade of NT-3–induced long-term changes in synaptic sites by inhibi-
tion of MAPK pathway. The MEK inhibitor U0126, but not the PKA 
  inhibitor Rp-cAMP or the CaMK inhibitor KN93, prevented the increase 
in synaptic sites induced by NT-3. The number associated with each col-
umn represents the number of cells analyzed. Data are presented as the 
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to the development of properly matched pre- and postsynap-
tic structures. For proper development of neuromuscular syn-
apse in vivo, both pathways have to be activated in concert. 
Having one ligand to trigger both pathways synchronously is 
an ideal way to coordinate the structural and functional devel-
opment of synapses. Similar mechanisms may also apply to 
synapse regeneration after injury. Local secretion of neuro-
trophins may ensure simultaneous morphological and physio-
logical   recoveries of the injured synapses. Thus, concomitant 
activation of these two pathways via pharmacological means 
may help treatment of nerve injuries or other neurodegenera-
tive diseases.
CaMKIV–CREB pathway mediates NT-3–
induced physiological changes at synapses
The transcription factor CREB has been extensively studied for 
its role in long-term, activity-dependent modulation of synapses 
in both vertebrates and invertebrates. In invertebrates, CREB 
has been shown to play a critical role in the long-term facilita-
tion (LTF) at the Aplysia sensory-motor synapses (Bailey et al., 
1996). Moreover, Davis et al. (1996) have shown that CREB is 
involved in functional, but not structural, plasticity at the 
D. melanogaster neuromuscular synapses. At mammalian hippo-
campal synapses, early studies suggest that CREB is also es-
sential for late-phase LTP (L-LTP; Bourtchuladze et al., 1994). 
In contrast, several recent studies indicated that CREB plays a 
more important role in cell survival than synaptic plasticity in 
the hippocampus (Pittenger et al., 2002; Balschun et al., 2003; 
Ramanan et al., 2005). However, expression of constitutively 
active CREB facilitates L-LTP, as well as long-term memory 
(Barco et al., 2002, 2005). Therefore, the specifi  c role of CREB 
in activity-dependent synaptic modulation in vertebrate is an 
interesting subject that requires further investigation. We have 
now shown that CREB mediates the long-term changes in syn-
aptic effi  cacy induced by NT-3. This is the fi  rst demonstration 
of the role of CREB in synaptic modulation by neurotrophins. 
Moreover, CREB is selectively involved in the physiological, but 
not morphological, changes of synapses induced by neurotrophins. 
These results suggest that activity-dependent and neurotrophin-
induced synaptic modulation may use different molecular mech-
anisms, and provide new insights into a complex, but important, 
problem in the fi  eld.
In vitro studies have shown that CREB can be phosphor-
ylated on Ser-133 by the following three signaling pathways: 
PKA, CaMKIV, and MAPK. However, specifi  c pathways lead-
ing to CREB activation in neurons under physiologically rel-
evant situations need to be worked out individually. Given that 
CREB is a key player in activity-dependent synaptic modula-
tion, there has been considerable interest in determining the 
specifi  c signaling events that activate CREB. Using cultured 
Figure 8.  Rap1, not Ras, is required for long-term morphological changes by NT-3. (A) Activation of Ras and Rap1 in NT-3–stimulated X. laevis spinal neurons. 
Intensity-modulated display images of spinal neurons expressing Raichu–Ras or –Rap1 and stimulated by NT-3. Bar, 10 μm. Yellow arrows indicate spots 
with increased level of Ras or Rap1 activity (B) Quantitative analysis of Ras and Rap1 activities in neuronal soma. The relative changes in ﬂ  uorescence 
intensity were monitored over time. n = 4. (C) Lack of effects of presynaptic expression of Dn-Ras or -Rap1 on NT-3–induced changes in SSC frequency. 
(D) Inhibition of NT-3–induced increase in synaptic site by presynaptic expression of Dn-Rap1, but not Dn-Ras. The number associated with each column 
represents the number of cells analyzed. Data are presented as the mean ± the SEM.JCB • VOLUME 175 • NUMBER 6 • 2006  1038
hippocampal neurons, some studies showed that neuronal 
 activity rapidly induces a translocation of calmodulin from cy-
tosol to nucleus and activation of CaMKIV, leading to CREB 
phosphorylation (Bito et al., 1996; Deisseroth et al., 1998; 
 Hardingham et al., 1999). In contrast, Impey et al. (1998) argued 
that Ras-ERK-Rsk2 is more important than CaMKIV in activat-
ing CREB. Subsequent work by Wu et al. (2001b) suggested 
that CaMKIV is responsible for the initial stage of fast CREB 
activation (2–10 min after stimulation), whereas MAPK is 
more effective in a later stage to promote a slow, but sustained, 
CREB phosphorylation. However, an activity-dependent rise 
in pCREB was greatly attenuated in both initial and late 
stages in CaMKIV-defi  cient mice (Ho et al., 2000; Ribar et al., 
2000). In transgenic mice overexpressing Dn-CaMKIV, activity-
dependent activation of CREB was selectively blocked, whereas 
that of MAPK was normal (Kang et al., 2001). These mice 
exhibit selective impairments in L-LTP, but not early-stage 
LTP, and in long-term memory, but not short-term memory. 
These results suggest that CaMKIV is a predominant pathway 
to CREB activation, and that the MAPK pathway can be sub-
sidiary or dispensable.
What is the signaling event that activates CREB during 
neurotrophin-induced synaptic potentiation? Our previous stud-
ies demonstrated that upon NT-3 application, there is a rise in 
intracellular Ca
2+, primarily through the release of Ca
2+ from 
IP3 receptor stores in X. laevis spinal neurons (He et al., 2000). 
We now showed that NT-3 induced the translocation of CaM 
into the nucleus, which is a prerequisite for CaMKIV activation. 
Furthermore, we found that CaMKIV is the only kinase that 
mediates NT-3–induced CREB phosphorylation, regardless of 
its temporal stages (Fig. 1, C and D). Most importantly, inhibi-
tion of CaMKIV, but not PKA or MAPK, blocked the NT-3–
induced synaptic potentiation. These results unequivocally 
defi  ne the CaMKIV–CREB pathway that mediates the NT-3–
induced synaptic potentiation.
Another interesting fi  nding is that inhibition of CREB 
  activity does not block the morphological changes in the nerve 
terminals induced by NT-3. This segregates the structural 
and functional alterations induced by the same neurotrophin. 
In Aplysia, injection of oligonucleotides containing multiple 
CRE-binding sites into the cell bodies of presynaptic sensory 
neurons represses both structural and functional changes un-
derlying LTF (Bartsch et al., 1995). In contrast, CREB func-
tion is only required in change of synaptic strength, but not 
synaptic growth, at the developing neuromuscular junction in 
D. melanogaster (Davis et al., 1996). In the mammalian hippo-
campus, although the specifi  c role of CREB in L-LTP remains 
debatable, it is generally agreed that CREB is important for 
long-term, activity-dependent modulation of synaptic effi  cacy 
(Silva et al., 1998; Kandel, 2001; Lonze and Ginty, 2002; West 
et al., 2002; Deisseroth et al., 2003). There is some evidence 
that CREB is involved in long-term structural changes of hippo-
campus synapses, but in these cases CREB acts downstream of 
hormones or trophic factors, rather than mediating the effects of 
neuronal activity (Murphy et al., 1998; O’Connell et al., 2000; 
Lee et al., 2004).
Why, then, is CREB involved in structural plasticity in 
some systems, but not in others? One possibility is that the neu-
romuscular synapse is a unique system where CREB is not in-
volved in structural plasticity. Alternatively, studies on Aplysia 
sensory motor synapses and hippocampal synapses deal with 
synaptic plasticity in the adult, whereas those using X. laevis 
nerve-muscle cocultures and D. melanogaster larvae NMJ re-
veal properties of developing synapses. A third possibility is 
that at the neuromuscular junction, CREB is activated strictly 
in presynaptic neurons, leading to transcription of genes impor-
tant for synaptic transmission and plasticity. In the hippocampal 
neurons, CREB is activated largely in postsynaptic neurons. 
It is conceivable that postsynaptic CREB activation may re-
sult in production of proteins involved in synaptic growth. 
Figure 9.  A model for mechanisms under-
lying long-term modulation of structures and 
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We   favor a different interpretation; whether CREB is involved 
in morphological changes at synapses or not may represent a 
fundamental difference between activity-dependent and neuro-
trophin-induced synaptic modulation. In any case, separation of 
structural and functional plasticity offers a unique opportunity 
to study the molecular mechanisms underlying long-term 
synaptic modulation.
Rap1–MAPK pathway mediates NT-3–
induced morphological changes at synapses
Numerous studies have revealed an undisputable role of MAPK 
in activity-dependent synaptic plasticity. In Aplysia, the activa-
tion of ApMAPK, the homologue of Mawkish associated with 
and necessary for the establishment of LTF (Bailey et al., 1997). 
  Substantial evidence indicates that MAPK is involved in both 
the induction and maintenance of L-LTP in the mammalian hippo-
campus (English and Sweatt, 1996; Rosenblum et al., 2002; 
Kelleher et al., 2004). If activity-dependent and neurotrophin-
  induced synaptic modulations share similar molecular mecha-
nisms, one would expect that MAPK be critically involved in 
synaptic potentiation induced by neurotrophins. Remarkably, 
MAPK is not required for the neurotrophin modulation of 
synaptic effi  cacy at the developing neuromuscular synapses. 
  Instead, it plays a critical role in the formation of synaptic boutons 
induced by NT-3. Again, our data support two main points: 
(1) molecular mechanisms underlying activity-dependent and 
neurotrophin-  induced synaptic modulation may be different; 
and (2) NT-3 triggers two parallel signaling pathways, which are 
separately re  sponsible for structural and functional maturation 
of the synapses.
The separation of physiological and morphological 
effects of NT-3 on synapses is quite intriguing. There are several 
examples in which manipulations altered synaptic morphology, 
but not physiology, or vice versa. In one case, retinal astrocytes 
secrete the extracellular matrix proteins thrombospondins, which 
increases the number of structural synapses that are function-
ally silent (Christopherson et al., 2005). Another example is that 
deletion of Munc18 in mice leads to a complete loss of func-
tional synaptic transmission, but ultrastructurally these synapses 
are completely normal (Verhage et al., 2000). It is possible that 
morphological development of synapses is not necessary for sim-
ple spontaneous and evoked synaptic transmission, but may be 
needed for the full-bloom capacity, plasti  city, or long-term sta-
bility of synapses. On the other hand, one may imagine that de-
velopment of synaptic structures through Rap1–MAPK pathway 
may not be suffi  cient, and additional molecular and functional 
elements must be in place to achieve fully functional synapses.
An interesting fi  nding was that Rap1, but not Ras, acts 
upstream of MAPK in mediating the increase in synaptic sites. 
How does Rap1 activation affect synaptic structure? One pos-
sibility is that only Rap1, but not Ras, mediates persistent 
MAPK activation, which may be required to trigger down-
stream signaling events necessary for structural plasticity. 
Parallel to this idea, previous studies indicate that NGF acti-
vates Ras through cell surface TrkA, leading to a transient 
activation of MAPK (York et al., 2000). In contrast, NGF-induced 
endocytosis of TrkA activates Rap1, resulting in sustained MAPK 
activity (Marshall, 1995; York et al., 2000; Wu et al., 2001a). 
Differences in the kinetics of MAPK activation may result in 
remarkably distinct cellular functions. In PC12 cells, transient 
activation of MAPK mediates proliferation, but sustained acti-
vation of MAPK induces differentiation (Marshall, 1995). We 
showed that application of NT-3 elicited a sustained activation 
of Rap1 localized largely in the cell body of spinal neurons, 
whereas Ras activation was transient and distributed throughout 
neuronal processes. Inhibition of Rap1, but not Ras, blocked the 
NT-3–induced MAPK activation and morphological changes of 
the nerve terminals. Rap1 may be involved in the signaling en-
dosome to activate transcription. We have previously shown that 
endocytosis of NT-3 and its cognate receptor is required for NT-3–
mediated long-term, but not short-term, synaptic modulation 
(Je et al., 2005). In PC12 cells, Rap1 and TrkA coprecipitate, 
and this signaling complex can affect MAPK activation (Wu 
et al., 2001a). Moreover, inhibition of receptor endocytosis at-
tenuates activation of MAPK, but increases activation of other 
kinases (Wu et al., 2001a). Collectively, these results support 
the notion that the endocytosis of NT-3–TrkC complex results 
in a persistent activation of Rap1 and MAPK, which in turn trig-
ger transcriptional activities that lead to the structural changes 
at the neuromuscular synapses.
An unsolved issue of Rap1–MAPK signaling in long-
term synaptic modulation by neurotrophins is the identifi  ca-
tion of downstream targets of MAPK responsible for changing 
presynaptic morphology. One possibility is that the activation 
of MAPK affects cell adhesion molecules (CAMs), thereby 
modifying synaptic structures. The MAPK cascade has long 
been recognized as being required for growth factor–induced 
differentiation and outgrowth of nerve terminals (Pang et al., 
1995; Perron and Bixby, 1999). In Aplysia, LTF elicits trans-
location of activated ApMAPK into the neuronal nucleus and 
subsequent internalization of ApCAM, a homologue of fasci-
clin II (FasII) in D. melanogaster and nerve CAMs in mam-
mals (Mayford et al., 1992). Mutation in MAPK or inhibition 
of MAPK phosphorylation in ApCAM blocks the internaliza-
tion of ApCAM, thereby preventing synaptic growth (Bailey 
et al., 1997; Martin et al., 1997). Similarly, at D. melanogaster 
NMJ, the modifi  cation of MAPK activity levels results in an 
altered number of synaptic boutons by affecting FasII localiza-
tion at synaptic boutons (Schuster et al., 1996a,b). Therefore, 
neurotrophic activation of MAPK may affect cell adhesion 
molecules or other downstream proteins to remodel synaptic 
morphology. Another possibility is that neurotro phins  may trig-
ger MAPK to activate transcription factors other than CREB. 
Adf1, a member of the Myb-related family of   transcription 
factors known to be activated by MAPK, has been shown 
to promote the development of synaptic   morphology in 
D. melanogaster NMJ; genetic manipulation that decrease 
(or increase) the amount of ADF1 gives rise to a decrease (or 
increase) in synaptic bouton numbers in D. melanogaster NMJ, 
without affecting synaptic strength (DeZazzo et al., 2000). 
However, synaptic proteins under ADF1 regulation or upstream 
of ADF1 have not yet been identifi  ed. Therefore, it will be inter-
esting to resolve downstream targets for neurotrophic activation 
of MAPK that mediate changes in synaptic morphology.JCB • VOLUME 175 • NUMBER 6 • 2006  1040
Materials and methods
DNA constructs, embryo injection, and X. laevis nerve-muscle coculture
dnCREB cDNA constructs (K- and A-CREB) were purchased from CLONTECH 
Laboratories, Inc. Dn-CaMKIV was a gift from M. Ehlers (Duke University 
Medical Center, Durham, NC). GFP-CaM expression vector was a gift from 
D. Chang (Hong Kong University of Science and Technology, Hong Kong, 
China). Dn-Ras and -Rap1a were gifts from A. Imamoto (University of 
Chicago, Chicago, IL). Raichu-Ras and -Rap1a were obtained from 
M. Matsuda (Osaka University, Osaka, Japan). cDNAs were digested and 
subcloned into the expression vector pcDNA3.1(+), which contains a T7 
promoter for in vitro transcription of sense mRNAs. Capped mRNAs were 
generated by using the mMessage mMachine kit (Ambion). X. laevis egg 
laying was induced by injecting female X. laevis with human chronic 
  gonadotropin (Sigma-Aldrich). Resulting eggs were fertilized artiﬁ  cially 
with sperms derived from male testis. mRNAs for NT-3, Dn forms of CREBs, 
Ras and Rap1a, or CaMKIV were mixed with 1 μg/μl GFP mRNA at a 1:1 
ratio. Approximately 6–12 nl of the solution was injected into one blasto-
mere at the 2- or 4-cell embryonic stage using the Picospitzer pressure 
ejector (Parker Hanniﬁ  n). 1 d after injection, the neural tube and associ-
ated myotomal tissues were dissected and used to prepare nerve-muscle 
cultures. Neural tube and associated myotomal tissue of X. laevis embryos 
at stage 20 were dissociated in Ca
2+-Mg
2+–free medium (58.2 mM NaCl, 
0.7 mM KCl, and 0.3 mM EDTA, pH 7.4) for 15–20 min. Cells were 
plated on clean glass coverslips and grown in the presence or absence of 
NT-3 (2 nM; a gift from Regeneron Pharmaceuticals, Tarrytown, NY) for 
2 d at room temperature, as previously described (Wang et al., 1995). The 
culture medium consisted (vol/vol) of 50% L-15 medium, 1% fetal calf 
serum, and 49% Ringer’s solution (117.6 mM NaCl, 2 mM CaCl2, 2.5 mM 
KCl, and 10 mM Hepes, pH 7.6). Various inhibitors and NT-3 were added 
to the cultures 6 h after plating, when cells were completely settled.
Electrophysiology
Synaptic currents were recorded from innervated muscle cells in 2- or 3-d-
old cultures by the whole-cell recording method in culture medium at room 
temperature (Wang et al., 1995). The internal pipette solution contained 
150 mM KCl, 1 mM NaCl, 1 mM MgCl2, and 10 mM Hepes buffer, pH 7.2. 
The membrane potentials of the muscle cells recorded were generally 
in the range of –55 to –75 mV and were voltage clamped at –70 mV. All 
data were collected by a patch clamp ampliﬁ  er (Axonpatch 200B; Axon 
Instruments), with a current signal ﬁ  lter set at 3 kHz. SSC frequency is de-
ﬁ  ned as the number of SSC events per minute. The amplitudes of SSCs 
were analyzed using SCAN software (Dagan). To elicit ESCs, square cur-
rent pulses (0.5–1 ms; 0.5–5 V) were applied to the soma of spinal neu-
rons with a patch electrode ﬁ  lled with Ringer’s solution at the neuronal 
soma under loose seal conditions (Yang et al., 2001). Pipette and mem-
brane capacitance and seal resistance were compensated. For acute 
effect, the data from a 10-min recording before application of NT-3 was 
taken as “control,” and those from a 10-min recording after the increase 
has reached peak as “NT-3 treated.” For long-term effect, a 10-min mean 
volume of SSC frequency/amplitude taken from any parts of the recording 
from a synapse gave rise to very similar numbers. For the convenience of 
comparison, we averaged data from control synapses without NT-3 treat-
ment (control), and normalized data from all other conditions to the control. 
The numbers in the graph bars represent the number of synapses examined 
(Figs. 2, 3, 5, 6, 8, S2, and S3).
Quantiﬁ  cation of synaptic sites and FM dye imaging
To visualize synaptic varicosity, we coinjected a small volume of a mixture, 
consisting of 2 μl of SYP-GFP plasmid DNA (1 μg/ml) and 2 μl of 
  rhodamine-conjugated dextran dye (molecular weight, 10,000 D), by em-
bryo injection. SYP-GFP construct was a gift from J. Sullivan (University of 
Washington, Seattle, WA). To label postsynaptic AChRs, 100 nM Cy5-labeled 
α-bungarotoxin (α-BTX) was applied to culture medium for 20 min. Cells 
were then rinsed extensively with Ringer’s solution to remove unbound 
α-BTX. Confocal imaging was performed using an inverted LSM 510 META 
laser scanning microscope using 1.3 NA oil-immersion objectives (both 
Carl Zeiss MicroImaging, Inc.). For triple-color imaging, excitation lines of 
a 488-nm argon laser and two 543- and 640-nm helium lasers were used. 
Fluorescence was detected using a 488-/543-/633-nm dichroic beam 
splitter and a 530–560-nm bandpass ﬁ  lter for SYP-GFP, a 580–620-nm 
bandpass ﬁ  lter for rhodamine, and a 650-nm long-pass ﬁ  lter for Cy5. With 
the narrow band-pass ﬁ   lters, any crossover or bleed-through of ﬂ  uores-
cence was eliminated. Postacquisition images were analyzed by IPLab 
software (Scanalytics). The criteria for synaptic puncta were that their ﬂ  uo-
rescence intensity must be >100% above the background and their size 
must be >0.5 μm in diameter. By using the region of interest (ROI) tool in 
the IPLab program, the number of synaptic sites, SYP-GFP puncta that juxta-
posed with Cy5-α-BTX puncta within a myocyte, were measured. The cal-
culated number of synaptic sites in a single myocyte per neuron were 
pooled and averaged. t tests were used for statistical analysis. The num-
bers in the bar graphs represent the number of cells used for morphological 
analysis (Figs. 1, 3 C, 4, 7 B, and S1 B). For FM dye imaging, the ﬂ  uores-
cent styryl membrane dye FM 4–64 (Invitrogen) was loaded into X. laevis 
spinal neurons by applying high K
+ loading solution (60 mM KCl, 57.6 
mM NaCl, 3.5 mM CaCl2, 10 mM Hepes, pH 7.6, and 2 μM FM 4–64) 
to cultures for 2 min. Cells were then rinsed extensively with Ringer’s solu-
tion to remove membrane-bound FM dye. Fluorescent images of FM-dye 
were acquired by a cool charge-coupled device camera (MicroMax 1300; 
Roper Scientiﬁ   c) mounted on an inverted epiﬂ  uorescence  microscope 
(IX70; Olympus) and analyzed. Fluorescence images were taken with 500-ms 
exposure time with a ×40, 0.55 NA, objective.
Western blotting
X. laevis embryos at stage 20 were quickly homogenized in extraction 
buffer (100 mM NaCl, 50 mM Tris-HCl, pH 7.5, 1% NP-40, 2 mM PMSF, 
1 μg/ml aprotinin, 1 μg/ml leupeptin, 1 μg/ml pepstatin A, and 2 μM 
Na3VO4) and subsequently sonicated. High-speed centrifugation produced 
an insoluble pellet that was discarded. Supernatants were transferred to a 
fresh tube containing 300 μl Freon (1,1,2-trichlorotriﬂ  uoroethane; Sigma-
Aldrich), vortexed for 1 min, incubated on ice for 5 min, and centrifuged 
again to remove yolk protein. The protein concentrations of the superna-
tants were determined using the BioRad protein assay (BioRad Laboratories). 
The proteins were separated by SDS-polyacrylamide electrophoresis, 
and blotted onto Immobilon-P membrane (Millipore). The blots were 
probed with primary antibodies, anti-CaM (1:100), and anti-GFP 
(1:10,000; Cell Signaling Technology), followed by a secondary antibody 
conjugated with HRP. Signals were detected by a chemiluminescence kit 
(Pierce Chemical Co.).
Immunocytochemistry
X. laevis nerve-muscle cultures were treated with or without pharmacologi-
cal drugs for 30 min at room temperature before NT-3 application. The 
cultured were ﬁ  xed 30 min after NT-3 application by using 4% paraformal-
dehyde (EM Science) for 30 min at room temperature, and washed three 
times with 0.1 M NaBH4 (sodium borohydrate) in PBS to reduce autoﬂ  uo-
rescence. Fixed cells were permeabilized with 0.1% Triton X-100 in PBS 
for 5 min. Fixed cells were blocked with 5% nonfat milk and incubated with 
primary antibodies against phospho-CREB 1:200 (Cell Signaling Technology) 
overnight at 4°C. Secondary antibody for immunoﬂ   uorescence was 
Alexa Fluor 546 (Invitrogen). To visualize DAB staining, an ABC kit (Vector 
Laboratories) was used. The images of immunocytochemistry were captured 
with an Olympus IX70 microscope using a charge-coupled device camera, 
acquired with IPLab software and processed with Photoshop (Adobe).
FRET-based Raichu-Rap and -Ras imaging
Confocal imaging was performed using an inverted LSM 510 laser scan-
ning microscope and 40×, 1.3 NA, or 63×, 1.3 NA, oil-immersion objec-
tives (all from Carl Zeiss MicroImaging, Inc.). For imaging coexpression of 
YFP and GFP constructs, excitation lines of a blue diode laser of 405 nm 
for both CFP and YFP were used. Fluorescence was detected using a 458-/
514-nm dichroic beam splitter and a 470–525-nm bandpass ﬁ  lter for CFP 
and a 530–590-nm bandpass ﬁ  lter for YFP. In this way, any cross-talk and 
bleed-through of ﬂ  uorescence were eliminated. Time-lapse scanning was 
performed with LSM 510 imaging system software. Post acquisition image 
processing was performed with the LSM 5 Image Browser (Carl Zeiss 
  MicroImaging, Inc.) and Photoshop 7.0 software (Adobe). X. laevis spinal 
neurons plated on a 35-mm diam coverslip were expressing pRaichu-
  derived plasmids by embryonic injection. A phase-contrast image and ﬂ  uo-
rescent images for ECFP and EYFP were recorded every 20 s. Starting from 
5 min, cells were stimulated with 10 ng/ml NT-3. We demonstrated cell 
images in intensity-modulated display (IMD) mode by MetaMorph software 
(Molecular Devices), according to the manufacturer’s instructions. In brief, 
background-subtracted images of EYFP and ECFP were ﬁ  rst used for calcu-
lating of the EYFP/ECFP ratio of each pixel. After determination of the 
  upper and lower thresholds, the ratio value of each pixel was associated 
with one of six hues from black (low) to white (high). The intensity of each pixel 
was determined by the brightness of ECFP. Thus, in IMD mode, the hue and 
its intensity at each pixel represent the FRET efﬁ  ciency and the probe con-
centration, respectively. The FRET images were collected every 20 s.MECHANISMS FOR STRUCTURAL AND FUNCTIONAL PLASTICITY • JE ET AL. 1041
Online supplemental material
Fig. S1 shows that NT-3 activates CREB. Fig. S2 shows the SSC ampli-
tude data for K-CREB, Dn-CaMKIV, and Dn-Ras, Dn-Rap1 (A–C), and SSC 
frequency data for Rp-cAMP. Fig. S3 shows that inhibition of CaMKIV 
activation does not prevent an acute effect of NT-3 on synaptic trans-
mission. Online supplemental material is available at http://www.jcb.
org/cgi/content/full/jcb.200603061/DC1.
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